posted on 2012-05-15, 00:00authored byRobin Roychaudhuri, Mingfeng Yang, Margaret M. Condron, David B. Teplow
Alzheimer’s disease (AD) is linked to the aberrant
assembly
of the amyloid β-protein (Aβ). The 21AEDVGSNKGA30 segment, Aβ(21–30), forms a turn that acts
as a monomer folding nucleus. Amino acid substitutions within this
nucleus cause familial forms of AD. To determine the biophysical characteristics
of the folding nucleus, we studied the biologically relevant acetyl-Aβ(21–30)-amide
peptide using experimental techniques (limited proteolysis, thermal
denaturation, urea denaturation followed by pulse proteolysis, and
electron microscopy) and computational methods (molecular dynamics).
Our results reveal a highly stable foldon and suggest new strategies
for therapeutic drug development.